1. Home
  2. ROIV vs AMCR Comparison

ROIV vs AMCR Comparison

Compare ROIV & AMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$28.58

Market Cap

20.7B

Sector

Health Care

ML Signal

HOLD

Logo Amcor plc

AMCR

Amcor plc

HOLD

Current Price

$43.28

Market Cap

20.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROIV
AMCR
Founded
2014
1926
Country
United Kingdom
Switzerland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Miscellaneous manufacturing industries
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
20.7B
20.4B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
ROIV
AMCR
Price
$28.58
$43.28
Analyst Decision
Strong Buy
Buy
Analyst Count
8
8
Target Price
$27.56
$53.67
AVG Volume (30 Days)
6.3M
4.7M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
5.95%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$29,053,000.00
N/A
Revenue This Year
N/A
$56.27
Revenue Next Year
$385.85
$1.47
P/E Ratio
N/A
$33.69
Revenue Growth
N/A
N/A
52 Week Low
$8.73
$7.67
52 Week High
$30.03
$50.94

Technical Indicators

Market Signals
Indicator
ROIV
AMCR
Relative Strength Index (RSI) 63.29 45.67
Support Level $20.46 $8.45
Resistance Level N/A $45.49
Average True Range (ATR) 0.95 1.09
MACD -0.00 -1.75
Stochastic Oscillator 66.80 8.67

Price Performance

Historical Comparison
ROIV
AMCR

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About AMCR Amcor plc

Amcor is a global producer of plastic packaging primarily for the fast-moving consumer goods industry. About 90% of earnings are exposed to the flexible packaging business. This is soft disposable plastic for a variety of food, drink, healthcare, and hygiene products. The remainder of earnings are from the Latin and North American rigids business, which is primarily beverage bottling for the soft drink industry. Operating in more than 35 countries, Amcor has market share in its established regions of North America, Latin America, Europe, and Asia-Pacific. About half of group sales are derived from North America and the remainder is split equally between Western Europe and emerging markets. Australia and New Zealand sales make up less than 5% of group sales.

Share on Social Networks: